4 ms·
The argument here is that the response that Solvadi is receiving now is the reason why that research isn't there - if you're afraid that the market may reject y
by gearhart 12y ago
The argument here is that the response that Solvadi is receiving now is the reason why that research isn't there - if you're afraid that the market may reject your pricing it's going to be very hard to justify doing the research in the first place, because you have no idea what the final value of it will be.
- CWuestefeld 12y agothe response that Solvadi is receiving now is the reason why that research isn't there This sword cuts both ways. Implicit in your response is that it's the potential income from American medical spending that's driving the investment in research: even if (or maybe because?) the income from other nations that structure health care expenses is used more wisely, it's not sufficient incentive to induce such research.